Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

NCT03322124 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Interventions

DRUG: Octenidinedihydrochlorid
OTHER: Placebo

Sponsor

Schülke & Mayr GmbH